Terms: = Leukemia AND TFG, TF6, 10342, ENSG00000114354, Q92734
8 results:
1. Genotypic and Phenotypic Characteristics of Acute Promyelocytic leukemia Translocation Variants.
Mannan A; Muhsen IN; Barragán E; Sanz MA; Mohty M; Hashmi SK; Aljurf M
Hematol Oncol Stem Cell Ther; 2020 Dec; 13(4):189-201. PubMed ID: 32473106
[TBL] [Abstract] [Full Text] [Related]
2. Detection of novel fusion-transcripts by RNA-Seq in T-cell lymphoblastic lymphoma.
López-Nieva P; Fernández-Navarro P; Graña-Castro O; Andrés-León E; Santos J; Villa-Morales M; Cobos-Fernández MÁ; González-Sánchez L; Malumbres M; Salazar-Roa M; Fernández-Piqueras J
Sci Rep; 2019 Mar; 9(1):5179. PubMed ID: 30914738
[TBL] [Abstract] [Full Text] [Related]
3. Cytotoxic activity of selected trifluoromethyl ketones against oral tumor cells.
Ideo A; Sasaki M; Nakamura C; Mori K; Shimada J; Kanda Y; Kunii S; Kawase M; Sakagami H
Anticancer Res; 2006; 26(6B):4335-41. PubMed ID: 17201152
[TBL] [Abstract] [Full Text] [Related]
4. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas.
Drexler HG; Gignac SM; von Wasielewski R; Werner M; Dirks WG
Leukemia; 2000 Sep; 14(9):1533-59. PubMed ID: 10994999
[TBL] [Abstract] [Full Text] [Related]
5. Transforming growth factor-beta and multidrug resistance in chronic lymphocytic leukemia.
Friedenberg WR; Salzman SA; Phan SM; Burmester JK
Med Oncol; 1999 Jul; 16(2):110-8. PubMed ID: 10456659
[TBL] [Abstract] [Full Text] [Related]
6. tfg/TAF30/ANC1, a component of the yeast SWI/SNF complex that is similar to the leukemogenic proteins ENL and AF-9.
Cairns BR; Henry NL; Kornberg RD
Mol Cell Biol; 1996 Jul; 16(7):3308-16. PubMed ID: 8668146
[TBL] [Abstract] [Full Text] [Related]
7. Investigation of calmodulin and basic fibroblast growth factor (bFGF) in idiopathic myelofibrosis: evidence for a role of extracellular calmodulin in fibroblast proliferation.
Dalley A; Smith JM; Reilly JT; Neil SM
Br J Haematol; 1996 Jun; 93(4):856-62. PubMed ID: 8703817
[TBL] [Abstract] [Full Text] [Related]
8. [Platelet factor 4 acts as both inhibitor and protector of hematopoietic precursor cells: possible mechanism of action].
Han ZC; Zhang XJ; Xi XD; Lu M; Jiang S; Jiang LZ; Wang XM; Gu GL; Caen JP
Shi Yan Sheng Wu Xue Bao; 1995 Dec; 28(4):415-26. PubMed ID: 8731973
[TBL] [Abstract] [Full Text] [Related]
